+1 (704) 266-3234

Global Pet Pharmaceuticals Market Research Report 2020

Published on: Mar 2020 | From USD $2900 | Published By: QY RESEARCH JAPANESE | Number Of Pages: 90


The global Pet Pharmaceuticals market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Pet Pharmaceuticals volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pet Pharmaceuticals market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Pet Pharmaceuticals market is segmented into
Pill
Injection
Spray
Ointment
Others

Segment by Application
Treatment
Prevention

Global Pet Pharmaceuticals Market: Regional Analysis
The Pet Pharmaceuticals market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Pet Pharmaceuticals market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Pet Pharmaceuticals Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Pet Pharmaceuticals market include:
Zoetis
Merck Animal Health
Merial
Elanco
Bayer
Boehringer Ingolheim
Novartis
Virbac Group
Ceva Sante Animale
VŽtoquinol S.A.

Table of Contents

1 Pet Pharmaceuticals Market Overview
1.1 Product Overview and Scope of Pet Pharmaceuticals
1.2 Pet Pharmaceuticals Segment by Type
1.2.1 Global Pet Pharmaceuticals Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Pill
1.2.3 Injection
1.2.4 Spray
1.2.5 Ointment
1.2.6 Others
1.3 Pet Pharmaceuticals Segment by Application
1.3.1 Pet Pharmaceuticals Sales Comparison by Application: 2020 VS 2026
1.3.2 Treatment
1.3.3 Prevention
1.4 Global Pet Pharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Pet Pharmaceuticals Revenue 2015-2026
1.4.2 Global Pet Pharmaceuticals Sales 2015-2026
1.4.3 Pet Pharmaceuticals Market Size by Region: 2020 Versus 2026

2 Global Pet Pharmaceuticals Market Competition by Manufacturers
2.1 Global Pet Pharmaceuticals Sales Market Share by Manufacturers (2015-2020)
2.2 Global Pet Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
2.3 Global Pet Pharmaceuticals Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Pet Pharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Pet Pharmaceuticals Market Competitive Situation and Trends
2.5.1 Pet Pharmaceuticals Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Pet Pharmaceuticals Players (Opinion Leaders)

3 Pet Pharmaceuticals Retrospective Market Scenario by Region
3.1 Global Pet Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Pet Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Pet Pharmaceuticals Market Facts & Figures by Country
3.3.1 North America Pet Pharmaceuticals Sales by Country
3.3.2 North America Pet Pharmaceuticals Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pet Pharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Pet Pharmaceuticals Sales by Country
3.4.2 Europe Pet Pharmaceuticals Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pet Pharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Pet Pharmaceuticals Sales by Region
3.5.2 Asia Pacific Pet Pharmaceuticals Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pet Pharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Pet Pharmaceuticals Sales by Country
3.6.2 Latin America Pet Pharmaceuticals Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Pet Pharmaceuticals Sales by Country
3.7.2 Middle East and Africa Pet Pharmaceuticals Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pet Pharmaceuticals Historic Market Analysis by Type
4.1 Global Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
4.2 Global Pet Pharmaceuticals Revenue Market Share by Type (2015-2020)
4.3 Global Pet Pharmaceuticals Price Market Share by Type (2015-2020)
4.4 Global Pet Pharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Pet Pharmaceuticals Historic Market Analysis by Application
5.1 Global Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
5.2 Global Pet Pharmaceuticals Revenue Market Share by Application (2015-2020)
5.3 Global Pet Pharmaceuticals Price by Application (2015-2020)

6 Company Profiles and Key Figures in Pet Pharmaceuticals Business
6.1 Zoetis
6.1.1 Corporation Information
6.1.2 Zoetis Description, Business Overview and Total Revenue
6.1.3 Zoetis Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Zoetis Products Offered
6.1.5 Zoetis Recent Development
6.2 Merck Animal Health
6.2.1 Merck Animal Health Pet Pharmaceuticals Production Sites and Area Served
6.2.2 Merck Animal Health Description, Business Overview and Total Revenue
6.2.3 Merck Animal Health Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Animal Health Products Offered
6.2.5 Merck Animal Health Recent Development
6.3 Merial
6.3.1 Merial Pet Pharmaceuticals Production Sites and Area Served
6.3.2 Merial Description, Business Overview and Total Revenue
6.3.3 Merial Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Merial Products Offered
6.3.5 Merial Recent Development
6.4 Elanco
6.4.1 Elanco Pet Pharmaceuticals Production Sites and Area Served
6.4.2 Elanco Description, Business Overview and Total Revenue
6.4.3 Elanco Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Elanco Products Offered
6.4.5 Elanco Recent Development
6.5 Bayer
6.5.1 Bayer Pet Pharmaceuticals Production Sites and Area Served
6.5.2 Bayer Description, Business Overview and Total Revenue
6.5.3 Bayer Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Bayer Products Offered
6.5.5 Bayer Recent Development
6.6 Boehringer Ingolheim
6.6.1 Boehringer Ingolheim Pet Pharmaceuticals Production Sites and Area Served
6.6.2 Boehringer Ingolheim Description, Business Overview and Total Revenue
6.6.3 Boehringer Ingolheim Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Boehringer Ingolheim Products Offered
6.6.5 Boehringer Ingolheim Recent Development
6.7 Novartis
6.6.1 Novartis Pet Pharmaceuticals Production Sites and Area Served
6.6.2 Novartis Description, Business Overview and Total Revenue
6.6.3 Novartis Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novartis Products Offered
6.7.5 Novartis Recent Development
6.8 Virbac Group
6.8.1 Virbac Group Pet Pharmaceuticals Production Sites and Area Served
6.8.2 Virbac Group Description, Business Overview and Total Revenue
6.8.3 Virbac Group Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Virbac Group Products Offered
6.8.5 Virbac Group Recent Development
6.9 Ceva Sante Animale
6.9.1 Ceva Sante Animale Pet Pharmaceuticals Production Sites and Area Served
6.9.2 Ceva Sante Animale Description, Business Overview and Total Revenue
6.9.3 Ceva Sante Animale Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Ceva Sante Animale Products Offered
6.9.5 Ceva Sante Animale Recent Development
6.10 VŽtoquinol S.A.
6.10.1 VŽtoquinol S.A. Pet Pharmaceuticals Production Sites and Area Served
6.10.2 VŽtoquinol S.A. Description, Business Overview and Total Revenue
6.10.3 VŽtoquinol S.A. Pet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.10.4 VŽtoquinol S.A. Products Offered
6.10.5 VŽtoquinol S.A. Recent Development

7 Pet Pharmaceuticals Manufacturing Cost Analysis
7.1 Pet Pharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pet Pharmaceuticals
7.4 Pet Pharmaceuticals Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pet Pharmaceuticals Distributors List
8.3 Pet Pharmaceuticals Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Pet Pharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pet Pharmaceuticals by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Pet Pharmaceuticals by Type (2021-2026)
10.2 Pet Pharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pet Pharmaceuticals by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Pet Pharmaceuticals by Application (2021-2026)
10.3 Pet Pharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pet Pharmaceuticals by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Pet Pharmaceuticals by Region (2021-2026)
10.4 North America Pet Pharmaceuticals Estimates and Projections (2021-2026)
10.5 Europe Pet Pharmaceuticals Estimates and Projections (2021-2026)
10.6 Asia Pacific Pet Pharmaceuticals Estimates and Projections (2021-2026)
10.7 Latin America Pet Pharmaceuticals Estimates and Projections (2021-2026)
10.8 Middle East and Africa Pet Pharmaceuticals Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Pet Pharmaceuticals Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Pet Pharmaceuticals Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Pet Pharmaceuticals Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Pet Pharmaceuticals Manufacturers Covered in This Study
Table 5. Global Pet Pharmaceuticals Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Pet Pharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 7. Global Pet Pharmaceuticals Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Pet Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Pet Pharmaceuticals Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Pet Pharmaceuticals Sales Sites and Area Served
Table 11. Manufacturers Pet Pharmaceuticals Product Types
Table 12. Global Pet Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pet Pharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Pharmaceuticals as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Pet Pharmaceuticals Players
Table 16. Global Pet Pharmaceuticals Sales (K MT) by Region (2015-2020)
Table 17. Global Pet Pharmaceuticals Sales Market Share by Region (2015-2020)
Table 18. Global Pet Pharmaceuticals Revenue (Million US$) by Region (2015-2020)
Table 19. Global Pet Pharmaceuticals Revenue Market Share by Region (2015-2020)
Table 20. North America Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 21. North America Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 22. North America Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 24. Europe Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 25. Europe Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 26. Europe Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Pet Pharmaceuticals Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Pet Pharmaceuticals Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Pet Pharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Pet Pharmaceuticals Revenue Market Share by Region (2015-2020)
Table 32. Latin America Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 33. Latin America Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 34. Latin America Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 40. Global Pet Pharmaceuticals Sales (K MT) by Type (2015-2020)
Table 41. Global Pet Pharmaceuticals Sales Share by Type (2015-2020)
Table 42. Global Pet Pharmaceuticals Revenue (Million US$) by Type (2015-2020)
Table 43. Global Pet Pharmaceuticals Revenue Share by Type (2015-2020)
Table 44. Global Pet Pharmaceuticals Price (USD/MT) by Type (2015-2020)
Table 45. Global Pet Pharmaceuticals Sales (K MT) by Application (2015-2020)
Table 46. Global Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 47. Global Pet Pharmaceuticals Sales Growth Rate by Application (2015-2020)
Table 48. Zoetis Pet Pharmaceuticals Corporation Information
Table 49. Zoetis Description and Business Overview
Table 50. Zoetis Pet Pharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Zoetis Main Product
Table 52. Zoetis Recent Development
Table 53. Merck Animal Health Pet Pharmaceuticals Corporation Information
Table 54. Merck Animal Health Corporation Information
Table 55. Merck Animal Health Pet Pharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Merck Animal Health Main Product
Table 57. Merck Animal Health Recent Development
Table 58. Merial Pet Pharmaceuticals Corporation Information
Table 59. Merial Corporation Information
Table 60. Merial Pet Pharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Merial Main Product
Table 62. Merial Recent Development
Table 63. Elanco Pet Pharmaceuticals Corporation Information
Table 64. Elanco Corporation Information
Table 65. Elanco Pet Pharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Elanco Main Product
Table 67. Elanco Recent Development
Table 68. Bayer Pet Pharmaceuticals Corporation Information
Table 69. Bayer Corporation Information
Table 70. Bayer Pet Pharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Bayer Main Product
Table 72. Bayer Recent Development
Table 73. Boehringer Ingolheim Pet Pharmaceuticals Corporation Information
Table 74. Boehringer Ingolheim Corporation Information
Table 75. Boehringer Ingolheim Pet Pharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Boehringer Ingolheim Main Product
Table 77. Boehringer Ingolheim Recent Development
Table 78. Novartis Pet Pharmaceuticals Corporation Information
Table 79. Novartis Corporation Information
Table 80. Novartis Pet Pharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Novartis Main Product
Table 82. Novartis Recent Development
Table 83. Virbac Group Pet Pharmaceuticals Corporation Information
Table 84. Virbac Group Corporation Information
Table 85. Virbac Group Pet Pharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Virbac Group Main Product
Table 87. Virbac Group Recent Development
Table 88. Ceva Sante Animale Pet Pharmaceuticals Corporation Information
Table 89. Ceva Sante Animale Corporation Information
Table 90. Ceva Sante Animale Pet Pharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Ceva Sante Animale Main Product
Table 92. Ceva Sante Animale Recent Development
Table 93. VŽtoquinol S.A. Pet Pharmaceuticals Corporation Information
Table 94. VŽtoquinol S.A. Corporation Information
Table 95. VŽtoquinol S.A. Pet Pharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. VŽtoquinol S.A. Main Product
Table 97. VŽtoquinol S.A. Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Pet Pharmaceuticals Distributors List
Table 101. Pet Pharmaceuticals Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Pet Pharmaceuticals Sales (K MT) Forecast by Type (2021-2026)
Table 106. Global Pet Pharmaceuticals Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Pet Pharmaceuticals Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Pet Pharmaceuticals Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Pet Pharmaceuticals Sales (K MT) Forecast by Application (2021-2026)
Table 110. Global Pet Pharmaceuticals Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Pet Pharmaceuticals Sales (K MT) Forecast by Region (2021-2026)
Table 112. Global Pet Pharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Pet Pharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Pet Pharmaceuticals Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Pet Pharmaceuticals
Figure 2. Global Pet Pharmaceuticals Sales Market Share by Type: 2020 VS 2026
Figure 3. Pill Product Picture
Figure 4. Injection Product Picture
Figure 5. Spray Product Picture
Figure 6. Ointment Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pet Pharmaceuticals Consumption Market Share by Application: 2020 VS 2026
Figure 9. Treatment
Figure 10. Prevention
Figure 11. Global Pet Pharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 12. Global Pet Pharmaceuticals Sales Capacity (K MT) (2015-2026)
Figure 13. Global Pet Pharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Pet Pharmaceuticals Sales Share by Manufacturers in 2020
Figure 15. Global Pet Pharmaceuticals Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Pet Pharmaceuticals Revenue in 2019
Figure 17. Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Pet Pharmaceuticals Sales Market Share by Region (2015-2020)
Figure 19. Global Pet Pharmaceuticals Sales Market Share by Region in 2019
Figure 20. Global Pet Pharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 21. Global Pet Pharmaceuticals Revenue Market Share by Region in 2019
Figure 22. North America Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 23. North America Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 24. U.S. Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 25. U.S. Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 27. Canada Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 29. Europe Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 30. Germany Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 31. Germany Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 33. France Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.K. Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 37. Italy Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 39. Russia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Pet Pharmaceuticals Sales Market Share by Region in 2019
Figure 41. Asia Pacific Pet Pharmaceuticals Revenue Market Share by Region in 2019
Figure 42. China Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 43. China Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 45. Japan Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 47. South Korea Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 49. India Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 51. Australia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 53. Taiwan Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 55. Indonesia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 57. Thailand Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 59. Malaysia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 61. Philippines Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 63. Vietnam Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 65. Latin America Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 66. Mexico Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 67. Mexico Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 69. Brazil Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 74. Turkey Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 75. Turkey Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 77. Saudi Arabia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 79. U.A.E Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Pet Pharmaceuticals by Type (2015-2020)
Figure 81. Sales Market Share of Pet Pharmaceuticals by Type in 2019
Figure 82. Revenue Share of Pet Pharmaceuticals by Type (2015-2020)
Figure 83. Revenue Market Share of Pet Pharmaceuticals by Type in 2019
Figure 84. Global Pet Pharmaceuticals Sales Growth by Type (2015-2020) (K MT)
Figure 85. Global Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Figure 86. Global Pet Pharmaceuticals Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Pet Pharmaceuticals by Application (2015-2020)
Figure 88. Global Revenue Share of Pet Pharmaceuticals by Application in 2020
Figure 89. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Merial Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Elanco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Boehringer Ingolheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Virbac Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. VŽtoquinol S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of Pet Pharmaceuticals
Figure 101. Manufacturing Process Analysis of Pet Pharmaceuticals
Figure 102. Pet Pharmaceuticals Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America Pet Pharmaceuticals Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 107. North America Pet Pharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Pet Pharmaceuticals Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Pet Pharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Pet Pharmaceuticals Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Pet Pharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Pet Pharmaceuticals Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Pet Pharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Pet Pharmaceuticals Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Pet Pharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $4350
USD $5800
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.